DE
62
2
BF.B
51
-2
ETN
67
3
ADT
50
5
HON
58
3
GM
44
4
HIG
78
6
BBY
36
3
KMI
77
4
HBAN
60
9
CCI
54
15
LH
50
2
PSA
60
2
O
39
2
HD
41
3
JNJ
56
-3
CCL
53
6
MSFT
51
4
EMC
71
18
FE
64
4
DE
62
2
BF.B
51
-2
ETN
67
3
ADT
50
5
HON
58
3
GM
44
4
HIG
78
6
BBY
36
3
KMI
77
4
HBAN
60
9
CCI
54
15
LH
50
2
PSA
60
2
O
39
2
HD
41
3
JNJ
56
-3
CCL
53
6
MSFT
51
4
EMC
71
18
FE
64
4
Financhill
Back

Vanda Pharmaceuticals 10K Form

Sell
42

VNDA
Vanda Pharmaceuticals

Last Price:
$4.99
Seasonality Move:
92.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-11-09 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-07-28 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-05-03 10Q VNDA/Vanda Pharmaceuticals Quarterly
2022-11-03 10Q VNDA/Vanda Pharmaceuticals Quarterly
2022-08-04 10Q VNDA/Vanda Pharmaceuticals Quarterly

Receive VNDA News And Ratings

See the #1 stock for the next 7 days that we like better than VNDA

VNDA Financial Statistics

Sales & Book Value

Annual Sales: $198.8M
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $9.24
Price / Book: 0.53

Profitability

EPS (TTM): -0.32000
Net Income (TTM): $-18.9M
Gross Margin: $187.5M
Return on Equity: -3.49%
Return on Assets: -2.9%

Vanda Pharmaceuticals Earnings Forecast

Key Vanda Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for VNDA is 94.31%.
  • The Selling, General & Administrative Expenses for VNDA have been equal to 73.66% of Gross Profit Margin.
  • The Research & Development expenses have been 37.45% of Revenue.
  • The Net Earning history of VNDA is -9.51% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 11 years.

Vanda Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VNDA
CUSIP: 921659
Website: vandapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.39
Quick Ratio: 4.22

Price-to-Earnings

Trailing P/E Ratio: 110.5
Forward P/E Ratio: 0

VNDA Technical Analysis vs Fundamental Analysis

Sell
42
Vanda Pharmaceuticals (VNDA) is a Sell

Is Vanda Pharmaceuticals a Buy or a Sell?